{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:08Z","timestamp":1753890968725,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016499","name":"Rett Syndrome Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016499","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Discov."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Rett Syndrome is a genetic neurodevelopmental disorder caused by decreased levels of MeCP2. Due to mutations in the <jats:italic>MECP2<\/jats:italic> gene, insufficient MeCP2 protein levels lead to clinical phenotypes including the loss of normal movement, decreased communication, seizures, sleep disorders, and breathing problems. Currently there is no cure for Rett Syndrome and the only means to help patients is palliative care directed to their specific symptoms. Therefore, novel therapies need to be developed to alleviate disease phenotypes by restoring normal <jats:italic>MECP2<\/jats:italic> expression. An autologous hematopoietic stem cell and gene therapy approach for Rett syndrome may offer a benefit to affected patients by systemic delivery of functional MeCP2, including to affected neurons in the central nervous system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In our current experiments, we evaluated the therapeutic effect of <jats:italic>MECP2<\/jats:italic> lentiviral vector transduced human CD34+ hematopoietic stem and progenitor cells after transplantation into an immunodeficient mouse model of Rett syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We observed improvement of Rett syndrome-related phenotypes including the reversion toward normal motor abilities in an open field assay for total activity, horizontal activity, and vertical rearing activity, and an increased latency to fall in a rotarod assay. An increased level of MeCP2 protein was also observed in the brain tissue of transplanted mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>By providing functional MeCP2 to affected cells, our results highlight the ability of this strategy to improve Rett syndrome phenotypes. These proof-of-concept studies demonstrate the potential use of a stem cell gene therapy approach as a novel treatment for Rett syndrome patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fddsv.2025.1545391","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:39:00Z","timestamp":1740119940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes"],"prefix":"10.3389","volume":"5","author":[{"given":"Joseph S.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill L.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyse L.","family":"Lodigiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla M.","family":"Barbaduomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"Beegle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/hmg\/ddab104","article-title":"Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells","volume":"30","author":"Adhikari","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/hmg\/ddm185","article-title":"Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis","volume":"16","author":"Alvarez-Saavedra","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e3717","DOI":"10.1002\/jgm.3717","article-title":"Hematopoietic stem cell gene therapy for the treatment of SYNGAP1-related non-specific intellectual disability","volume":"26","author":"Anderson","year":"2024","journal-title":"J. Gene Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e3205","DOI":"10.1002\/jgm.3205","article-title":"Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA\/HexB expressing lentiviral vector","volume":"22","author":"Beegle","year":"2020","journal-title":"J. Gene Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/hmg\/ddp181","article-title":"Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus","volume":"18","author":"Ben-Shachar","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"3209","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1073\/pnas.1505909112","article-title":"MeCP2 binds to nonCG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13052-018-0565-y","article-title":"Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches","volume":"44","author":"Fraldi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature14319","article-title":"Disruption of DNA-methylation-dependent long gene repression in Rett syndrome","volume":"522","author":"Gabel","year":"2015","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"32181","DOI":"10.1074\/jbc.M305308200","article-title":"Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation","volume":"278","author":"Georgel","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1084\/jem.194.8.1151","article-title":"Homeostasis of peripheral b cells in the absence of b cell influx from the bone marrow","volume":"194","author":"Hao","year":"2001","journal-title":"J. Exp. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng1491","article-title":"Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome","volume":"37","author":"Horike","year":"2005","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/s0387-7604(01)00345-x","article-title":"Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems","volume":"23","author":"Kudo","year":"2001","journal-title":"Brain Dev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1001\/jama.2022.19800","article-title":"Autologous gene therapy approved for childhood CALD","volume":"328","author":"Larkin","year":"2022","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI78167","article-title":"MECP2 disorders: from the clinic to mice and back","volume":"125","author":"Lombardi","year":"2015","journal-title":"J. Clin. Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.yhbeh.2010.05.014","article-title":"The role of MeCP2 in CNS development and function","volume":"59","author":"Na","year":"2011","journal-title":"Horm. Behav."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/s0387-7604(01)00333-3","article-title":"The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome","volume":"23","author":"Nan","year":"2001","journal-title":"Brain Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"eadd4666","DOI":"10.1126\/scitranslmed.add4666","article-title":"Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons","volume":"15","author":"Qian","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2+\/- mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/mt.2013.141","article-title":"Myeloid\/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease","volume":"21","author":"Sergijenko","year":"2013","journal-title":"Mol. Ther."},{"key":"B30","first-page":"153","article-title":"Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome","volume":"24","author":"Sinnett","year":"2017","journal-title":"Discov. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ymthe.2020.11.020","article-title":"Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases","volume":"29","author":"Tucci","year":"2021","journal-title":"Mol. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"19416","DOI":"10.1073\/pnas.0707442104","article-title":"Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes","volume":"104","author":"Yasui","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/382228","article-title":"X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome","volume":"74","author":"Young","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1128\/MCB.02454-05","article-title":"Active chromatin hub of the mouse alpha-globin locus forms in a transcription factory of clustered housekeeping genes","volume":"26","author":"Zhou","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1021\/bi0521083","article-title":"Chromatin assembly factor 1 interacts with histone H3 methylated at lysine 79 in the processes of epigenetic silencing and DNA repair","volume":"45","author":"Zhou","year":"2006","journal-title":"Biochemistry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.conb.2019.07.002","article-title":"Genomic insights into MeCP2 function: a role for the maintenance of chromatin architecture","volume":"59","author":"Zhou","year":"2019","journal-title":"Curr. Opin. Neurobiol."}],"container-title":["Frontiers in Drug Discovery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2025.1545391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:39:03Z","timestamp":1740119943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2025.1545391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":37,"alternative-id":["10.3389\/fddsv.2025.1545391"],"URL":"https:\/\/doi.org\/10.3389\/fddsv.2025.1545391","relation":{},"ISSN":["2674-0338"],"issn-type":[{"type":"electronic","value":"2674-0338"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"article-number":"1545391"}}